We’ve been talking a lot this week about the ACA price linked subsidy system. I’m hammering this point home because the subsidy structure as it is currently written into law has weird incentives and linkages. We need to understand these linkages for spread sensitive cohorts to understand the lived experience on the ground with current policy and proposed future policy.
Let’s build a simple model. Let us assume that there are two buyers. The first buyer is not subsidized. They are level sensitive. The second buyer is subsidized. They are expected to pay $150 in net premium for the benchmark plan. There are three classes of plans available. There are plans priced below the benchmark. There is a plan priced as the benchmark. Finally there are plans priced above the benchmark.
We’ll run this universe three times. The first time is our baseline. The second time there is a general 20% reduction in premium from the baseline. The third scenario has a 20% increase in premiums for all plans. (All numbers are hypothetical and we should seldom expect uniform percentage change in premiums but as a teaching example, this is good enough for a first pass to develop intuition)
We get what our intuition tells us to expect for the level sensitive, non-subsidized buyer; when premiums go up, they pay more, and when premiums go down they pay less. This is simple.
It gets messy with subsidized buyers. A change in premium level affects subsidized buyers differently depending on what class of plan they buy. Subsidized buyers who purchase the benchmark plan pay the same price in all three scenarios. They are completely indifferent to premium levels.
But they are the only people who are completely indifferent to premium levels as changings in levels becomes a change in spread.
Lower premium levels reduces the spread between the benchmark plan and the below benchmark plan. Lower premium levels increases the net premium paid by people who purchase lower cost plans. These folks are worse off. However, people who want to purchase a plan that is priced above benchmark will see their net premium decrease when there is a general reduction in all plan premium levels. These folks are better off. They might be buying a richer benefit plan (gold instead of silver) or a broad network PPO instead of a narrow network HMO, but they get more for less premium.
Higher premium levels increase the spread between the benchmark and the below benchmark plan. Really high premium levels can theoretically reduce the net premium paid for below benchmark plans to zero. Below benchmark plan buyers are better off with a high general premium level. Buyers of above benchmark plans are worse off as they pay more in net premiums every month when premium levels increase.
Within the context of the ACA individual market, most subsidized buyers are purchasing either the benchmark plan or a plan priced below benchmark. This means that most of the population is either indifferent or actively benefits from higher premium levels. It is not everyone. Anyone who buys a platinum plan benefits from lower premium levels, and people who are fairly broad network non-restrictive and low cost-sharing plans are almost always worse off when premium levels increase.
These dynamics are complex. They are confusing. And they shape the distributional consequences as well as the operational mechanics of most of the ACA individual market now and under most plausible reform plans. We need to understand these mechanisms well.
Ken
Wonkiest title of 2021, or wonkiest title ever?
guachi
It’s still weird to see that a uniform % increase in insurance costs will actually lower the net premium paid by a subsidized customer.
David Anderson
@guachi: YES!
This stuff is fundamentally weird.
David Anderson
@Ken: This post from 2019 can compete:
HRAs and downward nominal wage rigidity
https://balloon-juice.com/2019/01/03/hras-and-downward-nominal-wage-rigidity/
Ken
@David Anderson: Hmm, yes, though longer generally reads as wonkier. BTW I do read your articles, though I sometimes don’t understand them – rather like my relation with Derek Lowe’s blog on medicinal chemistry. This one I did get, despite the wonky title.
Another Scott
Thanks for this.
But doesn’t it get even more complex when one considers total out of pocket costs? I understand that there are specified requirement for cost-sharing for Silver plans and so forth, but do the annual changes in subsidies or not affect total out of pocket costs?
Say Family X typically has $5000 in potential out-of-pocket medical costs every year and are $1 below the current 400% of the poverty line limit. In addition to levels and spreads, do they have to consider changes in deductibles and co-pays and so forth when they’re looking between plans? Or do plans in each metal band have similar end-user out of pocket costs?
Basically, in Warner’s plan and others that are being proposed, if more people are eligible for subsidies, can the insurance companies mess around with the coverage so that they collect more money from the insured while also getting more from the federal government? Or are they totally separate issues? My gut feeling is that people really, really like stuff that is “free” or has no apparent cost to them every month. But then they get really, really pissed off if/when they find that their “insurance” doesn’t actually reduce their net medical bills every year.
Thanks.
Cheers,
Scott.
David Anderson
@Another Scott: fairly separate issues. This was most of my day today on a variety of phone calls and many of my meetings.